Crime & Law · India
Maharashtra FDA Cancels Cipla's Pune Unit Drug Sale Licence
The Maharashtra Food and Drug Administration (FDA) has cancelled the drug sale licence for Cipla Pharma & Life Sciences' C&F (Carriage and Forwarding) unit in Wadki, Pune. The cancellation is reportedly due to 'unauthorised promotional text' and issues related to the drug 'Reactin Plus'. The FDA's action affects the unit's ability to sell drugs. The specific reasons cited by the FDA relate to promotional activities and the drug Reactin Plus.
How outlets across the spectrum covered it
L 0 C 5 R 0
- Centre (5): DNA (Daily News & Analysis), Outlook India, The Economic Times, The Free Press Journal, The Statesman